Skip to main content

Qsymia (Phentermine and Topiramate Extended Release) & Patient Characteristics

    Basic Details
    Status
    Complete
    Last Updated
    Wednesday, August 7, 2019
    Health Outcome(s)
    patient characteristics
    Purpose
    Drug Utilization
    Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
    No
    Study Summary

    Contributed important information regarding potentially viable sources of information to evaluate cardiovascular risk.